Agreement between HbA1c measured by DCA 2000 and by HPLC: Effects of fetal hemoglobin concentrations

Archives of Medical Research

Volumn 35, Issue 2, 2004, Pages 145-149

  Diem, Peter ^a   Wälchli, Manuela ^a   Mullis, Primus E ^a   Marti, Ulrich ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Fetal hemoglobin; Glycohemoglobin; Hemoglobin A1c

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HEMOGLOBIN F;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ANALYZER; ARTICLE; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; REPRODUCIBILITY; BIOSYNTHESIS; BLOOD; BLOOD ANALYSIS; BLOOD EXAMINATION; COMPARATIVE STUDY; ION EXCHANGE CHROMATOGRAPHY; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; BLOOD CHEMICAL ANALYSIS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; DIABETES MELLITUS, TYPE 1; FEMALE; FETAL HEMOGLOBIN; HEMATOLOGIC TESTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; LINEAR MODELS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 1542328914     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2003.10.003     Document Type: Article

References (26)

1. 1 and diabetes: a reappraisal (editorial). BMJ. 281:1980;1304-1305.
2. Goldstein D.E., Parker K.M., England J.D., England J.E. Jr., Wiedmeyer H.M., Rawlings S.S., Hess R., Little R.R., Simonds J.F., Breyfogle R.P. Clinical applications of glycosylated hemoglobin measurements. Diabetes. 31:(Suppl 3):1982;70-78.
3. Svendsen P.A., Lauritzen T., Søegaard U., Nerup J. Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes. Diabetologia. 23:1982;403-405.
4. Nathan D.M., Singer D.E., Hurxthal K., Goodson J.D. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med. 310:1984;341-346.
5. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:1993;977-986.
6. Prospective Diabetes Study UK. (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
7. http://web.missouri.edu/~diabetes/ngsp/index.html.
8. 1c system in pediatric outpatient population. Diabetes Care. 15:1992;1045-1049.
9. 1c by using precalibrated, unitized reagent cartridges. (abstract) Clin Chem. 38:1992;1647.
10. 1c. Diabetes Care. 15:1992;1494-1498.
11. 1c. Clin Chem. 38:1992;2372-2379.
12. Mullis P., Schuler J., Zuppinger K. Increased prevalence of fetal haemoglobin in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 32:1989;227-230.
13. Diem P., Mullis P., Hirt A., Schuler J.J., Bürgi W., Zuppinger K.A., Teuscher A. Fetal haemoglobin levels in adult type 1 (insulin-dependent) diabetic patients. Diabetologia. 36:1993;129-132.
14. Kilpatrick E.S., Small M., Rumley A., Dominiczak M.H. Increased fetal hemoglobin in insulin-treated diabetes mellitus contributes to the imprecision of glycohemoglobin measurements. Clin Chem. 39:1993;833-835.
15. Koskinen L.K., Koivula T.A., Lahtela J.T. Fetal hemoglobin in diabetic patients. Diabetes Care. 17:1994;828-831.
16. Robertson D.A., Tunbridge F.K., John W.G., Home P.D., Alberti K.G.M.M. Diagnostic confusion in diabetes with persistence of fetal haemoglobin. BMJ. 305:1992;635-637.
17. Cornbleet P.J., Gochman N. Incorrect least-squares regression coefficients in method comparison analysis. Clin Chem. 25:1979;432-438.
18. 1c. Biochem Clin. 14:(Suppl 2):1990;14.
19. 1c. Diabetes. 35:(Suppl 1):1986;94A.
20. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. (i):1986;307-310.
21. Saunders J., Baron M.D., Shenoda F.S., Sönksen P.H. Measuring glycosylated haemoglobin concentrations in a diabetic clinic. BMJ. 281:1990;1394-1395.
22. Goldstein D.E., Little R.R. More than you ever wanted to know (but need to know) about glycohemoglobin testing. Diabetes Care. 17:1994;938-939.
23. 1c measured by turbidimetric inhibition immunoassay. Am J Clin Pathol. 109:1998;274-278.
24. Matteucci E., Miloni C., Biasci E., Bertoni C., Boldrini E., Giampietro O. With regard to glycohemoglobin measurement: are we sure that high-performance liquid chromatography currently works in clinical routine? Acta Diabetol. 35:1998;41-47.
25. 1c. Acta Diabetol. 37:2000;1-7.
26. Weykamp C.W., Penders T.J., Siebelder C.W.M., Muskiet F.A.J., van der Slik W. Interferences of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography and enzyme immunoassay. Clin Chem. 39:1993;138-142.